Impact of prior paclitaxel-based chemotherapy on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT): EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study

被引：0

作者：

Necchi, A. ^{[1
]}

Miceli, R. ^{[2
]}

Bregni, M. ^{[3
]}

Berger, L. A. ^{[4
]}

Oechsle, K. ^{[4
]}

Schumacher, K. ^{[5
]}

Apperley, J. ^{[6
]}

Bourhis, J. H. ^{[7
]}

Laszlo, D. ^{[8
]}

Flechon, A. ^{[9
]}

Arpaci, F. ^{[10
]}

Secondino, S. ^{[11
]}

Dreger, P. ^{[12
]}

Crysandt, M. ^{[13
]}

Plueger, K. H. ^{[14
]}

Worel, N. ^{[15
]}

Krueger, W. ^{[16
]}

Ringhoffer, M. ^{[17
]}

Unal, A. ^{[18
]}

Nagler, A. ^{[19
]}

Michieli, M. ^{[20
]}

Campos, A. ^{[21
]}

Wahlin, A. ^{[22
]}

Sucak, G. ^{[23
]}

Schots, R. ^{[24
]}

Donnini, I. ^{[25
]}

Raggi, D. ^{[1
]}

Giannatempo, P. ^{[1
]}

Ifrah, N. ^{[26
]}

Badoglio, M. ^{[27
]}

Martino, M. ^{[28
]}

Pedrazzoli, P. ^{[11
]}

Lanza, F. ^{[29
]}

机构：

[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Clin Epidemiol & Trials Org Unit, Milan, Italy

[3] Azienda Osped Busto Arsizio, Med Oncol, Busto Arsizio, Italy

[4] KMT Univ Klinikum Hamburg Eppendorf, Med Oncol, Hamburg, Germany

[5] UKGM Marburg Klin Hematol & Oncol, Med Oncol, Marburg, Germany

[6] Univ London Imperial Coll Sci Technol & Med, Hematol, London, England

[7] Gustave Roussy Inst Cancerol, Hematol BMT, Villejuif, France

[8] European Inst Oncol, Hematol BMT, Milan, Italy

[9] Ctr Leon Berard, Hematol, F-69373 Lyon, France

[10] Gulhane Mil Med Acad, GATA BMT Ctr, Ankara, Turkey

[11] Fdn IRCCS Policlin San Matteo, Med Oncol, Pavia, Italy

[12] Univ Klinikum Heidelberg, Hematol, Heidelberg, Germany

[13] Univ Hosp Aachen, Dept Oncol Hematol & SCT, Med Klin 4, Aachen, Germany

[14] EV Diakonie Krankenhaus Gemeinnitzige GmbH, Hematol, Bremen, Germany

[15] Med Univ Vienna, BMT Unit, Vienna, Austria

[16] Univ Med, Klin Innere Med Hamat Onkol C, Greifswal, Germany

[17] Klinikum Karlsruhe gGmbH, Med Klin Haematol 3, Onkol, Karlsruhe, Germany

[18] Kapadokya Cappadocia BMT Ctr, Erciyes Med Sch, Dept Hematol Oncol, Kayseri, Turkey

[19] Chaim Sheba Med Ctr, BMT Unit, IL-52621 Tel Hashomer, Israel

[20] IRCCS Aviano, CRO, Hematol, Aviano, Italy

[21] Inst Portugues Oncol Porto, BMT Unit, Oporto, Portugal

[22] Umea Univ Hosp, Hematol, Umea, Sweden

[23] Gazi Univ Med, Dept Hematol & Stem Cell Transplantat, Ankara, Turkey

[24] Univ Ziekenhuis Brussel, Div Clin Hematol, Brussels, Belgium

[25] Univ Hosp Careggi, BMT Unit, Florence, Italy

[26] CHRU Angers, BMT Unit, Angers, France

[27] EBMT, EBMT Study Off, Paris, France

[28] Azienda Osped BMM, Hematol & Bone Marrow Transplant Unit, Reggio Di Calabria, Italy

[29] Ist Ospitalieri Cremona, Hematol & Bone Marrow Transplant Unit, Cremona, Italy

来源：

BONE MARROW TRANSPLANTATION | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O094

引用

页码：S55 / S55

页数：1

共 50 条

[41] Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)
Adra, Nabil
Althouse, Sandra K.
Abonour, Rafat
Abu Zaid, Mohammad Issam
Liu, Hao
Hanna, Nasser H.
Einhorn, Lawrence
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[42] Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
Oyan, B
Koc, Y
ANNALS OF ONCOLOGY, 2006, 17 (02) : 349 - 350
[43] Consolidative high-dose chemotherapy (HDCT) after conventional-dose chemotherapy (CDCT) as first salvage treatment for male patients (pts) with metastatic germ cell tumors (mGCTs).
Beausoleil, Michel S.
Potvin, Kylea R.
Howson-Jan, Kang
Ernst, D. Scott
Stitt, Larry
Winquist, Eric
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[44] Efficacy of epirubicin-paclitaxel (EPI-TAX) prior to high-dose chemotherapy (HDCT) in germ cell tumors (GCTs): A 17-year experience.
Lotz, Jean-Pierre
Soares, Daniele Grazziotin
Culine, Stephane
Laverdant, Benjamin
Kieffer, Anne
Dabi, Yohann
Gligorov, Joseph
Selle, Frederic
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[45] Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors
Nieto, Y.
Tu, S. -M.
Bassett, R.
Jones, R. B.
Gulbis, A. M.
Tannir, N.
Kingham, A.
Ledesma, C.
Margolin, K.
Holmberg, L.
Champlin, R.
Pagliaro, L.
ANNALS OF ONCOLOGY, 2015, 26 (10) : 2125 - 2132
[46] High-dose chemotherapy (HDCT) and autologous peripheral-blood stem cell transplant (PBSCT) for relapsed metastatic germ-cell tumors (mGCT): The Indiana University (IU) experience.
Adra, Nabil
Althouse, Sandra
Brames, Mary J.
Sullivan, Cheryl K.
Abonour, Rafat
Hanna, Nasser H.
Albany, Costantine
Einhorn, Lawrence H.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[47] LONG-TERM OUTCOME OF PATIENTS WITH RELAPSED AND REFRACTORY GERM-CELL TUMORS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW RESCUE
BROUN, ER
NICHOLS, CR
KNEEBONE, P
WILLIAMS, SD
LOEHRER, PJ
EINHORN, LH
TRICOT, GJK
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) : 124 - 128
[48] High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
Secondino, S.
Badoglio, M.
Rosti, G.
Labopin, M.
Delaye, M.
Bokemeyer, C.
Seidel, C.
Kanfer, E.
Metafuni, E.
Finke, J.
Bouhris, J. -h.
Kosmas, C.
Malard, F.
Pagani, A.
Kuball, J.
Koehl, U.
Ruggeri, A.
De Giorgi, U.
Pedrazzoli, P.
ESMO OPEN, 2024, 9 (09)
[49] Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT).
Kilari, Deepak
Hari, Parameswaran
Qayed, Muna
Fraser, Raphael
Davila, Omar
Kumar, Shaji
Mark, Tomer Martin
Nieto, Yago
D'Souza, Anita
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[50] LONG-TERM RESULTS WITH HIGH-DOSE CHEMOTHERAPY IN ADULT PATIENTS WITH EXTRAGONADAL GERM CELL TUMORS: THE EXPERIENCE OF THE EUROPEAN BONE MARROW TRANSPLANTATION (EBMT) SOLID TUMOURS WORKING PARTY
Demirer, Taner
De Giorgi, Ugo
Papiani, Giorgio
Rosti, Giovanni
ANNALS OF ONCOLOGY, 2004, 15 : 97 - 97

← 1 2 3 4 5 →